Tenaya Therapeutics appoints Karah Parschauer to Board and Joanna Auch as SVP of People and Culture

Tenaya Therapeutics, Inc.

Board expanded to 10 members; Karah Parschauer appointed as Class I director and audit committee member.
Parschauer receives $35k annual cash retainer, $7.5k audit committee retainer, and ~$320k stock option grant.
Joanna Auch appointed as SVP of People and Culture; previously Head of HR North America at Santen.
Both appointments effective December 22, 2021; Parschauer's term expires at 2022 annual meeting.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Karah Parschauer

Director

TNYA · Tenaya Therapeutics, Inc.

Effective: 2021-12-22
Filed: December 22, 2021, 6:59 PM ET

appointed Karah Parschauer to the Board and as a member of the audit committee of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Karah Parschauer was appointed as Director at Tenaya Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Karah Parschauer to the Board and as a member of the audit committee of the Board

View on SEC.gov

Tenaya Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-365119

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.